Send to

Choose Destination
Curr Opin Pharmacol. 2006 Aug;6(4):369-75. Epub 2006 Jun 14.

Histone deacetylase inhibitors: gathering pace.

Author information

Topo Target, 87A Milton Park, Abingdon, Oxford OX14 4RY, UK.


Reversible histone acetylation is one of the key mechanisms involved in the epigenetic control of gene expression. A variety of recent studies has revealed a role for acetylation in a much broader repertoire of physiological processes, including proliferation control and protein folding, and has highlighted how a variety of non-histone regulatory proteins are influenced by acetylation. Inhibition of histone deacetylase (HDAC) prompts tumour cells to enter apoptosis and, as a consequence, several HDAC inhibitors have entered clinical trials. It is likely that HDAC inhibitor drugs will provide an important class of new mechanism-based therapeutics for cancer.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center